Nova Scotia Health Employees' Pension Plan v. Comerica Incorporated
Opinion
NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS FEB 6 2026 MOLLY C. DWYER, CLERK
U.S. COURT OF APPEALS
FOR THE NINTH CIRCUIT
NOVA SCOTIA HEALTH EMPLOYEES' No. 24-7673 PENSION PLAN, Lead Plaintiff, D.C. No.
2:23-cv-06843-SB-JPR
Plaintiff - Appellant,
and MEMORANDUM* DAVID RAMOS, Plaintiff,
v.
COMERICA INCORPORATED; CURTIS C. FARMER; JAMES J. HERZOG,
Defendants - Appellees.
Appeal from the United States District Court for the Central District of California Stanley Blumenfeld, Jr., District Judge, Presiding
Submitted February 4, 2026** Pasadena, California
Before: LEE, KOH, and DE ALBA, Circuit Judges.
*
This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3.
**
The panel unanimously concludes this case is suitable for decision without oral argument. See Fed. R. App. P. 34(a)(2).
Appellants Nova Scotia Health Employees’ Pension Plan (“NSHEPP”) and David Ramos brought this putative securities class action under Sections 10(b) and 20(a) of the Securities Exchange Act and Rule 10b-5 against Appellees Comerica Incorporated (“Comerica”); Comerica’s CEO, Curtis C. Farmer (“Farmer”); and Comerica’s CFO, James J. Herzog. On appeal, Appellants argue that the district court erred in dismissing the Third Amended Complaint (“TAC”) for failure to state a claim, denying leave to amend, and denying reconsideration. We have jurisdiction under 28 U.S.C. § 1291, and we affirm.
We review the district court’s dismissal of a complaint for failure to state a claim de novo. “On review, we accept the plaintiffs’ allegations as true and construe them in the light most favorable to plaintiffs.” In re Gilead Scis. Sec. Litig., 536 F.3d 1049, 1055 (9th Cir. 2008) (quoting Gompper v. VISX, Inc., 298 F.3d 893, 895 (9th Cir. 2002)). “The court need not, however, accept as true allegations that . . . . are merely conclusory, unwarranted deductions of fact, or unreasonable inferences.” Sprewell v. Golden State Warriors, 266 F.3d 979, 988 (9th Cir. 2001) (citation omitted), amended on other grounds, 275 F.3d 1187 (9th Cir. 2001). “We review the denial of leave to amend for an abuse of discretion, but we review the question of futility of amendment de novo.” B&G Foods N. Am., Inc. v. Embry, 29 F.4th 527, 534 (9th Cir. 2022) (quoting United States v. United Healthcare Ins. Co., 848 F.3d 1161, 1172 (9th Cir. 2016)). We review denial of a
motion for reconsideration for abuse of discretion. Phelps v. Alameida, 569 F.3d 1120, 1131 (9th Cir. 2009).
1. NSHEPP alleged that Comerica, as Financial Agent of the Department of Treasury’s Bureau of Fiscal Service’s (“Fiscal Service”) Direct Express program, violated the governing regulations and contractual requirements of the Direct Express program, and that Comerica and its executives committed securities fraud by hiding the violations. The district court correctly dismissed the TAC for failure to adequately allege that Appellees’ fraud caused Appellants’ loss.
Loss causation, “i.e., a causal connection between the material misrepresentation and the loss” is a basic element of a Section 10(b) claim. Dura Pharms., Inc. v. Broudo, 544 U.S. 336, 342 (2005).1 “So long as the complaint alleges facts that, if taken as true, plausibly establish loss causation, a Rule 12(b)(6) dismissal is inappropriate.” Gilead, 536 F.3d at 1057.
“Loss causation is established if the market learns of a defendant’s fraudulent act or practice, the market reacts to the fraudulent act or practice, and a plaintiff suffers a loss as a result of the market’s reaction.” In re Oracle Corp. Sec. Litig., 627 F.3d 376, 392 (9th Cir. 2010). “The most common way for plaintiffs to
1 NSHEPP’s Section 20(a) claim depends on its Section 10(b) claim. See Zucco Partners, LLC v. Digimarc Corp., 552 F.3d 981, 990 (9th Cir. 2009) (“Section 20(a) claims may be dismissed summarily . . . if a plaintiff fails to adequately plead a primary violation of section 10(b).”).
prove that the truth became known is to identify one or more corrective disclosures. A corrective disclosure occurs when information correcting the misstatement or omission that is the basis for the action is disseminated to the market.” In re BofI Holding, Inc. Sec. Litig., 977 F.3d 781, 790 (9th Cir. 2020) (internal quotes and citations omitted).
NSHEPP alleged that three corrective disclosures revealed risks regarding Comerica’s probability of being renewed as Financial Agent for the Direct Express Program.2 The district court correctly concluded that none of these alleged disclosures established loss causation.
A. First Disclosure and Alleged Re-concealment The first alleged disclosure is a May 29, 2023 American Banker article (“AB Article”) that NSHEPP alleges revealed compliance issues with two third-party vendors. The AB Article revealed information from nonpublic documents indicating that Comerica’s two third-party vendors, i2c Inc. (“i2c”) and Conduent Business Services (“Conduent”), had failed to follow regulatory and contractual requirements for processing Direct Express cardholder disputes. Among other violations in processing cardholding disputes, the AB Article revealed that i2c had
2 Before the district court, NSHEPP also argued that various analyst reports correlated with “small price drops” constituted corrective disclosures. The district court concluded that none of the reports constituted corrective disclosures because these reports largely pre-dated the AB Article and were unrelated to the Direct Express program. None of these reports are a basis for NSHEPP’s appeal.
processed Direct Express cardholder disputes in Pakistan, which violated the FAA’s requirement that all Direct Express services be provided in the United States by United States citizens or lawful permanent residents. The AB Article also summarized already public information showing that Comerica had long been subject to various complaints and investigations regarding its compliance deficiencies and dispute processing procedures, including a congressional investigation in 2018, a class action lawsuit in 2019, and audits by the Treasury’s Office of Inspector General (“OIG”) with reports published in 2014, 2017, and 2020.
Because Comerica’s stock price decline following the AB Article was modest, typical, and quickly reversed, NSHEPP has not plausibly alleged that the fraud disclosed by the AB Article caused Comerica’s drop in stock price. Where there is a “quick and sustained [stock] price recovery after the modest . . . drop” that follows the alleged corrective disclosure, the recovery “refutes the inference that the alleged concealment of [the] fact caused any material drop in the stock price.” Wochos v. Tesla, Inc., 985 F.3d 1180, 1198 (9th Cir. 2021). A fall in share price of 10% or less may be considered modest. See Metzler Inv. GMBH v. Corinthian Colleges, Inc., 540 F.3d 1049, 1064 (9th Cir. 2008) (holding that plaintiff failed to plead loss causation where defendant’s “stock recovered very shortly after the modest 10% drop”).
Specifically, Comerica’s stock decreased by a total of 7.4% over two days after the AB Article was published on May 29, 2023, which is smaller than the 10% drop that this court considered “modest” in Metzler, 540 F.3d at 1064. Additionally, the May 30 and 31, 2023 price decreases followed a trend of declining stock prices over the previous several days. This drop was well within Comerica’s typical stock price movement and reversed over the next two days. Beginning June 2, 2023 through late September 2023, for approximately four months, Comerica’s stock price remained higher than it had been before the AB Article was published.
Free access — add to your briefcase to read the full text and ask questions with AI
Nova Scotia Health Employees' Pension Plan v. Comerica Incorporated (Nova Scotia Health Employees' Pension Plan v. Comerica Incorporated) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.